Cas:51096-49-2 (S)-2-Benzylamino-1-phenyl-ethanol manufacturer & supplier

We serve Chemical Name:(S)-2-Benzylamino-1-phenyl-ethanol CAS:51096-49-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(S)-2-Benzylamino-1-phenyl-ethanol

Chemical Name:(S)-2-Benzylamino-1-phenyl-ethanol
CAS.NO:51096-49-2
Synonyms:(S)-(+)-2-Benzylamino-1-phenylethanol;(1S)-2-(Benzylamino)-1-phenylethanol;(S)-2-Benzylamino-1-phenyl-ethanol;Benzenemethanol, α-[[(phenylmethyl)amino]methyl]-, (αS)-;MFCD03427123
Molecular Formula:C15H17NO
Molecular Weight:227.30200
HS Code:2922199090

Physical and Chemical Properties:
Melting point:115-118ºC
Boiling point:375.2ºC at 760 mmHg
Density:1.1g/cm3
Index of Refraction:1.593
PSA:32.26000
Exact Mass:227.13100
LogP:2.90070

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like (S)-(+)-2-Benzylamino-1-phenylethanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD03427123 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-2-Benzylamino-1-phenyl-ethanol Use and application,Benzenemethanol, α-[[(phenylmethyl)amino]methyl]-, (αS)- technical grade,usp/ep/jp grade.


Related News: The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. (S)-2-Benzylamino-1-phenyl-ethanol manufacturer From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats. (S)-2-Benzylamino-1-phenyl-ethanol supplier The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. (S)-2-Benzylamino-1-phenyl-ethanol vendor From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats. (S)-2-Benzylamino-1-phenyl-ethanol factory From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.